Renal Cancer: Contemporary Management

This fully updated third edition provides a comprehensive, state-of- the-art review of renal cancer, and will serve as a guide for urology residents, clinicians, surgeons, and researchers with an interest in renal cell carcinoma. The title will review the latest information regarding: epidemiology, clinical staging, molecular biology and genetics, hereditary syndromes, pathology, imaging, molecular imaging, interventional radiology, surgical advances, and the unified approach to surgery and systemic therapy of renal cell carcinoma. It also addresses the management of localized RCC, locally advanced disease, and systemically advanced disease. 

A valuable resource for physicians and researchers dealing with renal cancer, Renal Cancer: Contemporary Management, Third Edition will provide a comprehensive summary of the field that will guide patient management and stimulate further clinical and basics science research efforts.

Dr. Libertino currently serves as Professor of Urology at Tufts University School of Medicine. He previously served as CEO, Director of the Cancer Center, Chair of Surgery, and Chair of Urology at Lahey Hospital and Medical Center. Dr. Libertino received his M.D. degree from the Georgetown University School of Medicine, where he also was an NIH fellow in cardiovascular research. He completed his residency in urology at the Yale University School of Medicine, where he also served as a Harvey Cushing fellow in Surgery.

Dr. Gee is an associate professor of urology at the Tufts University School of Medicine. Dr. Gee received his medical degree from Harvard University school of medicine with distinction. He was a resident in general surgery on the Harvard surgical service at the Beth Israel Deaconess Medical Center. He completed his urologic residency at the Lahey Clinic Medical Center. Following his urology residency he completed a three year fellowship in urologic oncology at the MD Anderson Cancer Center in Houston, Texas.